I'd like to begin with a summary of our financial results for the fourth quarter and for the full year 2025 on Slide three. We delivered strong financial results in both the fourth quarter and full year 2025 as we continue to execute in our long-term growth strategy. Full-year revenue and earnings per share reached record levels, driven by a 41% increase in product revenue to $348 million due to DDR5 market share gains and new product contributions. In 2025, we generated a company record $360 million in cash from operations, which was up 56% from 2024. An established track record of generating cash enables us to invest in initiatives that fuel our long-term growth. Let me now provide you a summary of our non-GAAP income statement on Slide five. Revenue for the fourth quarter was $190.2 million, which is above our expectations. Royalty revenue was $71.7 million, but licensing billings were $71.5 million. Product revenue was $96.8 million as we delivered another quarter of record product revenue. This represents 32% year-over-year growth driven by continued strength in DDR5 products and ramping new product contributions. For the full year, we delivered $347.8 million in product revenue, which was a new annual record for the company. Contract and other revenue was $21.8 million, consisting predominantly of Silicon IP. As a reminder, only a portion of our silicon IP revenue is reflected in contract and other revenue, and the remaining portion is reported in royalty revenue as well as in licensing billings. Total operating costs, including the cost of goods sold for the quarter, were $103.2 million. Operating expenses of $64.9 million were in line with our expectations and flat compared to Q3. Interest and other income for the fourth quarter was $6.4 million. Using an assumed flat tax rate of 20% for non-GAAP pretax income, non-GAAP net income for the quarter was $74.7 million. Now let me turn to the balance sheet details on Slide six. We ended the quarter with cash, cash equivalents, and marketable securities totaling $761.8 million, up from Q3, primarily driven by record cash from operations of $99.8 million. Fourth-quarter capital expenditures were $8.6 million, with depreciation expense at $8.4 million. Free cash flow in the quarter was $91.2 million, and for the full year, we delivered $320.9 million or a 45% free cash flow margin. Let me now review our non-GAAP outlook for the first quarter on Slide seven. As a reminder, the forward-looking guidance reflects our best estimate at this time, and our actual results could differ materially from what I'm about to review. In addition to the non-GAAP financial outlook under ASC 606, we also provide information on licensing billings, which is an operational metric that reflects amounts invoiced to our licensing customers during the period adjusted for certain differences. We expect revenue in the first quarter to be between $172 million and $108 million. We expect royalty revenue to be between $61 million and $67 million and licensing billings between $66 million and $72 million. As Luc mentioned earlier, our Q1 product revenue is impacted by a supply chain issue, which has been resolved, and we expect resumption of growth from the second quarter onwards. We expect Q1 non-GAAP total operating costs, which includes COGS, to be between $104 million and $100 million. We expect Q1 capital expenditures to be approximately $13 million. Non-GAAP operating results for the first quarter are expected to be between a profit of $68 million and $78 million. For non-GAAP interest and other income and expense, we expect $6 million of interest income. We expect our pro forma tax rate for 2026 will be 16%, driven by tax legislation changes last year. We expect non-GAAP tax expenses to be between 11.8% and $13.4 million in Q1. We expect Q1 share count to be 110 million diluted shares outstanding. Overall, we anticipate the Q1 non-GAAP earnings per share range between $0.56 and $0.64. Let me finish with a summary on slide eight. In closing, I am pleased with our excellent 2025 financial performance and the continued progress we are making against our strategic goals. We delivered record top-line revenue growth resulting in record profitability and cash generation. Our diversified portfolio continues to be a core strength for the company. First, patented licensing continues to deliver consistent results. Also, our silicon IP portfolio is well-positioned to address the accelerating demand for AI solutions. In addition, our product business continues to drive our growth with strong leadership and market share gains in our core RCD business, which is complemented by our expanding new product contributions.